Many diseases are hereditary; for example, Huntington's disease and cystic fibrosis. Other diseases affected by genes, such as diabetes and cancer. Many advances make possible a solution to target such hereditary infections at subatomic levels, and thus offer the possibility of viable new treatments (McClean, 1999). The qualities of substantial cells (somatic cells) can be controlled to modify a disease in a person. If the qualities of germ cells are altered, hereditary disease can also be avoided (McClean, 1999). Application of genetic engineering Debates on the quality of treatments require understanding certain aspects of fundamental science. Genes comprise deoxyribonucleic acid, also known as DNA, and they repeat during cell division, transmitting the data they encode to ensure all ages of cells and life forms (Sade, nd). Genes become useful through a chain of biochemical events: DNA in the cell nucleus is transcribed, by base coordination, into ribonucleic acid (mRNA), which at this point leaves the cell nucleus, it attaches to cytosomal ribosomes and is converted into proteins by mixing its bases with amino acids. Control of the amount of protein delivered occurs through various mechanisms, including the creation of repressor and activator proteins, which maintain the presence of various amounts of protein (Sade, n.d.). Say no to plagiarism. Get a tailor-made essay on “Why Violent Video Games Should Not Be Banned”? Get the original essay Inherited DNA causes changes in both the structure and measurements of the proteins it ultimately creates (Sade, n.d.). Lately, many strategies have been developed to recognize genes linked to particular diseases. Since 1990, when the main agreements for quality treatment were approved, more than 100 new research agreements have been launched for a range of diseases, including cancer, HIV infection, cystic fibrosis (CF) and many more. others (Pike, 2000). Possible future treatment for diseases such as Duchenne and hemoglobin disorders like sickle cell anemia and beta thalassemia may be possible in the near future (Pike, 2000). Due to somatic cell treatments, the nature of a specific disease and different variables determine the particular cells targeted for hereditary control. Target cells include lung, liver, white blood, endothelial and cancer cells (Pike, 2000). All reviews to date have included somatic cells and the strategies used to cause unrealistic propagation of engineered germ cells. Regardless, it seems likely that we will eventually have the ability to alter the qualities of germ cells, with the goal that the progressions will be made and passed on to the subjects' offspring (Pike, 2000). Quality treatment of somatic cells, target cells that can be modified both in vitro and then integrated into the host, or in vivo. In current treatments (all of which involve substantial cells), vectors are used to introduce new hereditary material into target cells (Sade, n.d.). Vectors are operators to which new hereditary material is added. The first attempts to treat inequality used retroviral vectors (Yash, 2015). Retroviruses are RNA infections, which enter cells and use catalytic reverse transcriptase to transform RNA into DNA (DNA,).